Publicacións en colaboración con investigadores/as de University of Bristol (6)

2019

  1. Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials

    Human Vaccines and Immunotherapeutics, Vol. 15, Núm. 12, pp. 2865-2872

  2. Quality of life impact of an adjuvanted recombinant zoster vaccine in adults aged 50 years and older

    Journals of Gerontology - Series A Biological Sciences and Medical Sciences, Vol. 74, Núm. 8, pp. 1231-1238

2018

  1. Clinical and laboratory features of children with community-acquired pneumonia are associated with distinct radiographic presentations

    European Journal of Pediatrics, Vol. 177, Núm. 7, pp. 1111-1120

2017

  1. Persistence of immunity after vaccination with a capsular group B meningococcal vaccine in 3 different toddler schedules

    CMAJ, Vol. 189, Núm. 41, pp. E1276-E1285

2016

  1. Persistence of bactericidal antibodies after infant serogroup B meningococcal immunization and booster dose response at 12, 18 or 24 months of age

    Pediatric Infectious Disease Journal

2012

  1. Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: A randomized controlled trial

    JAMA, Vol. 307, Núm. 6, pp. 573-582